print logo

METOXIA partners

METOXIA is a five year research project with 21 partner institutions in 11 European countries.

Partner Main scientific contact person Additional information
University of Oslo, Norway (1/UIO) Erik O. Pettersen  Peter Ebbesen, Hilde Hvistendahl
Stichting Maastricht Radiation Oncology, The Netherlands (2/MAASTRO) Philippe Lambin Department of Radiation Oncology, MAASTRO lab
University of Edinburgh, UK (3/UEDIN) Ian Kunkler  
Radboud University Nijmegen Medical Centre, The Netherlands (4/RUNMC) Johannes HAM Kaanders Albert Van der Kogel,
University of Oxford, UK (5/UOXF.BP) Adrian L. Harris  
University Hospital Aarhus, Denmark (6/AUH,AS) Morten Busk  Jens Overgaard, Michael R. Horseman,
FMC Biopolymer AS, Norway (7/FMC) Michael Dornish  
University of Manchester, UK (8/UNIMAN) Kaye J. Williams  
Universita Degli studi di Firenze, Italy (9/UNIFI) Andrea Scozzafava  Claudiu Supuran
Karolinska Institutet, Sweden (10/KI) Lorenz Poellinger, Yihai Cao  
Universidad Autonoma de Madrid, Spain (11/MAD) Manuel O. de Landazuri  
Deutsches Herzzentrum an der TU, Germany (12/DHZM) Agnes Görlach  
Centre National de la Recherche Scientifique, France (13/CNRS) Jacques Pouyssegur  
Albert Ludwig Universität, Germany (14/ALU) Gerald Urban  
Jobst Technologies GmbH, Germany (15/JOBST) Gerhard Jobst  
ViVoX ApS, Denmark (16/VIVOX) Jan Villadsen  
University College of London, UK (17/UCL) Patrick Maxwell/ Margareth Ascroft Patrick Maxwell from 2013 at University of Cambridge.
Virologicky ustav Slovenskej Akademie Vied, Slovakia (18/IVSAS) Silvia Pastorekova  

Biotechnologijos Institutas, Lithuania (19/IBT)

Arvydas Kanopka Laboratory of Immunology and Cell Biology , at Vilniaus Universitetas, Biotechnologijos Institutas
Universiteit Maastricht, The Netherlands (20/GROW-UM) Brad Wouters GROW School for Oncology and Developmental Biology
Oslo Universitetssykeshus*, Norway (21/OU)

Heidi Lyng, Gunnar Kvalheim

Rikshospitalet-Radiumhospitalet HF(7/RIKS) merged with Ullevål Universitetssykeshus (17/UUS) and is now part of Oslo Universitetssykeshus (21/OU). Jens Kjeldsen Kragh left METOXIA in 2012.

 * Oslo Universitetssykeshus (21/OU) is the merging of the two initial partners Rikshospitalet-Radiumhospitalet HF(7/RIKS) and Ullevål Universitetssykehus(17/UUS)

Published May 6, 2010 2:31 PM - Last modified Sep. 28, 2014 4:55 PM